Chemoinformaics analysis of N-Butyl-Levulinate
Molecular Weight | 172.224 | nRot | 6 |
Heavy Atom Molecular Weight | 156.096 | nRig | 2 |
Exact Molecular Weight | 172.11 | nRing | 0 |
Solubility: LogS | -1.654 | nHRing | 0 |
Solubility: LogP | 1.163 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 28.1047 |
nHD | 0 | BPOL | 19.5233 |
QED | 0.452 |
Synth | 1.869 |
Natural Product Likeliness | 0.249 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.614 |
Pgp-sub | 0.005 |
HIA | 0.004 |
CACO-2 | -4.461 |
MDCK | 0.0000295 |
BBB | 0.994 |
PPB | 0.471624 |
VDSS | 0.441 |
FU | 0.639395 |
CYP1A2-inh | 0.774 |
CYP1A2-sub | 0.502 |
CYP2c19-inh | 0.429 |
CYP2c19-sub | 0.728 |
CYP2c9-inh | 0.113 |
CYP2c9-sub | 0.753 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.385 |
CYP3a4-inh | 0.03 |
CYP3a4-sub | 0.218 |
CL | 10.213 |
T12 | 0.895 |
hERG | 0.065 |
Ames | 0.009 |
ROA | 0.012 |
SkinSen | 0.383 |
Carcinogencity | 0.074 |
EI | 0.977 |
Respiratory | 0.034 |
NR-Aromatase | 0.014 |
Antiviral | No |
Prediction | 0.927766 |